NEWARK, N.J., Feb. 07, 2025 (GLOBE NEWSWIRE) -- NRSInsights, a provider of sales data and analytics drawn from retail ...

Recent research has revealed the most unhealthy cities in the UK which factors in obesity, alcohol consumption and tobacco so you might want to keep reading to see if your city is named and shamed ...

Real-time index price for TSX Renewable and Clean Tech Index (TXCT), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

Novo Nordisk has a dominant position in diabetes and weight-loss drugs, strong financial growth outlook, and great potential. Click to read why NVO is a Strong Buy.

By David Leonhardt Graphics by Ashley Wu Total G.D.P. Among high-income countries and China China $30 trillion $25 But by ...

Prime Minister Narendra Modi’s initiative to combat obesity and reduce oil consumption has been welcomed by the medical ...

Dialysis Centers used data from the Centers for Disease Control and Prevention to examine the prevalence of chronic diseases in the U.S.

In November 2023 Colombia imposed a tax on highly processed foods and drinks. Authorities in Brazil, Canada and Peru have ...

In Japan, interest rates are set by the Bank of Japan's Policy Board in its Monetary Policy Meetings. The BoJ's official interest rate is the discount rate. Monetary Policy Meetings produce a ...

Novo Nordisk (NYSE:NVO) shares are rallying 6.87% to $86.67 as of 10:27 AM ET Friday, after the company reported promising trial results for its new obesity drug, amycretin. Warning! GuruFocus has ...

Viking Therapeutics, Inc. offers promising advances in obesity and liver diseases, despite a recent stock drop over GLP-1 market concerns. Click for my VKTX update.